Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein.

Nozaki A, Ikeda M, Naganuma A, Nakamura T, Inudoh M, Tanaka K, Kato N.

J Biol Chem. 2003 Mar 21;278(12):10162-73. Epub 2003 Jan 9.

2.

Hepatitis C virus envelope proteins bind lactoferrin.

Yi M, Kaneko S, Yu DY, Murakami S.

J Virol. 1997 Aug;71(8):5997-6002.

3.

Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.

Allander T, Forns X, Emerson SU, Purcell RH, Bukh J.

Virology. 2000 Nov 25;277(2):358-67.

4.

Helical peptides derived from lactoferrin bind hepatitis C virus envelope protein E2.

Beleid R, Douglas D, Kneteman N, Kaur K.

Chem Biol Drug Des. 2008 Nov;72(5):436-43. doi: 10.1111/j.1747-0285.2008.00715.x.

5.

Hepatitis C virus glycoprotein E2 binding to CD81: the role of E1E2 cleavage and protein glycosylation in bioactivity.

Chan-Fook C, Jiang WR, Clarke BE, Zitzmann N, Maidens C, McKeating JA, Jones IM.

Virology. 2000 Jul 20;273(1):60-6.

6.

Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2.

Yi M, Nakamoto Y, Kaneko S, Yamashita T, Murakami S.

Virology. 1997 Apr 28;231(1):119-29.

7.

Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.

Hofmann WP, Sarrazin C, Kronenberger B, Schönberger B, Bruch K, Zeuzem S.

J Infect Dis. 2003 Mar 15;187(6):982-7. Epub 2003 Mar 6.

PMID:
12660945
8.

Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells.

Mazzocca A, Sciammetta SC, Carloni V, Cosmi L, Annunziato F, Harada T, Abrignani S, Pinzani M.

J Biol Chem. 2005 Mar 25;280(12):11329-39. Epub 2004 Dec 16.

9.

Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes.

Abe K, Nozaki A, Tamura K, Ikeda M, Naka K, Dansako H, Hoshino HO, Tanaka K, Kato N.

Microbiol Immunol. 2007;51(1):117-25.

10.

Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2.

Drummer HE, Wilson KA, Poumbourios P.

Biochem Biophys Res Commun. 2005 Mar 4;328(1):251-7.

PMID:
15670777
11.

A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.

Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R.

Antiviral Res. 2010 May;86(2):172-9. doi: 10.1016/j.antiviral.2010.02.316. Epub 2010 Feb 13.

PMID:
20156485
12.
13.

Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression.

Kronenberger B, Sarrazin C, Hofmann WP, von Wagner M, Herrmann E, Welsch C, Elez R, Rüster B, Piiper A, Zeuzem S.

J Viral Hepat. 2004 Jul;11(4):310-8.

PMID:
15230853
14.

Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.

Wagner CE, Mohler ML, Kang GS, Miller DD, Geisert EE, Chang YA, Fleischer EB, Shea KJ.

J Med Chem. 2003 Jul 3;46(14):2823-33.

PMID:
12825926
15.

Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81.

Cao J, Liao XL, Wu SM, Zhao P, Zhao LJ, Wu WB, Qi ZT.

J Microbiol Methods. 2007 Mar;68(3):601-4. Epub 2006 Dec 18.

PMID:
17178166
16.

Structural characterization of peptide fragments from hCD81-LEL.

Dhanasekaran M, Baures PW, VanCompernolle S, Todd S, Prakash O.

J Pept Res. 2003 Feb;61(2):80-9.

PMID:
12492902
17.

CD81 binding regions of hepatitis C virus remain conserved after liver transplantation.

Lyra AC, Fan X, Di Bisceglie AM.

Braz J Infect Dis. 2004 Apr;8(2):126-32. Epub 2004 Sep 8.

PMID:
15361990
18.

Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding.

McCaffrey K, Boo I, Poumbourios P, Drummer HE.

J Virol. 2007 Sep;81(17):9584-90. Epub 2007 Jun 20.

19.

Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.

Ikeda M, Sugiyama K, Tanaka T, Tanaka K, Sekihara H, Shimotohno K, Kato N.

Biochem Biophys Res Commun. 1998 Apr 17;245(2):549-53.

PMID:
9571193
20.

Supplemental Content

Support Center